Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx O
Recalled March 22, 2017 · FDA recall D-0520-2017 · Amerisource Health Services
Hazard
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point. · FDA Class II
Units
19,393 cartons (581,790 extended release tablets)
Sold at
Nationwide
Description
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
Product
GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21
Manufacturer(s)
Amerisource Health Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →